| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 01/03/2001 | EP1064298A2 Inhibitors of caspases |
| 01/03/2001 | EP1064274A1 Benzenesulfonamide derivatives and their use as medicaments |
| 01/03/2001 | EP1063982A2 Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders |
| 01/03/2001 | CN1278793A Sulfonyl derivatives |
| 01/03/2001 | CN1278530A Novel peptide derivative |
| 01/02/2001 | US6169186 Liquid crystals and liquid crystalline polymers |
| 01/02/2001 | US6169108 Wherein crystal is substantially free from hygroscopicity; by using anhydrous crystal for manufacture of a medicament comprising the compound as an active material a product with constant content of active ingredient can be obtained |
| 01/02/2001 | US6169094 Compositions of (S) (-)-amisulpride |
| 01/02/2001 | US6168912 Converting in parallel, a set of at least two different alpha-allyl carbonyl monomers of defined structure, then oligomerizing through a heteroatom |
| 01/02/2001 | CA2068064C Fibrinogen receptor antagonists |
| 01/02/2001 | CA2054850C Cyclic imino derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 01/02/2001 | CA2017934C Nitrogen-containing titanocenes, and the use thereof |
| 01/02/2001 | CA2009604C Diaryl-substituted heterocyclic compounds, their preparation and drugs and cosmetics obtained therefrom |
| 01/02/2001 | CA1341161C Quinolone- and naphthyridone carboxylic acid derivatives, process for their production, antibacterial compositions and feed additives containing them |
| 01/02/2001 | CA1341159C Pure enantiomers of 4,5-disubstituted .alpha.-butyrolactams, process for their preparation, and their use |
| 12/28/2000 | WO2000078846A1 Degradable cross-linking agents and cross-linked network polymers formed therewith |
| 12/28/2000 | WO2000078734A1 Substituted herbicidal phenyluracils |
| 12/28/2000 | WO2000078715A1 Synthesis of a novel paramagnetic amino acid derivative (epm-5) for labelling chemical and biological macromolecules |
| 12/28/2000 | WO2000078714A2 Succinimides as paper sizing agents |
| 12/28/2000 | WO2000078707A1 C-2 hydroxyl protected-n-acyl(2r,3s)-3-phenylisoserine activated esters and methods for production thereof |
| 12/28/2000 | WO2000078308A1 Antibiotic compound |
| 12/28/2000 | DE19929086A1 New pyrrole derivatives used as fungicides, bactericides and insecticides prepared e.g. from novel pyrrole acetic ester and methylation agent |
| 12/28/2000 | CA2392210A1 Degradable cross-linking agents and cross-linked network polymers formed therewith |
| 12/28/2000 | CA2376007A1 Antibiotic compound |
| 12/28/2000 | CA2375343A1 C-2 hydroxyl protected-n-acyl(2r,3s)-3-phenylisoserine activated esters and methods for production thereof |
| 12/28/2000 | CA2375243A1 Substituted herbicidal phenyluracils |
| 12/27/2000 | EP1063230A1 Cyclic amino compounds |
| 12/27/2000 | EP1063223A1 Polyenepolycarboxylic acids, derivatives thereof with respect to carboxyl groups, or salts of these |
| 12/27/2000 | EP1062218A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 12/27/2000 | EP1062204A1 Modulators of protein tyrosine phosphatases (ptpases) |
| 12/27/2000 | CN1278269A Piperazine-cyclodextrin complexes |
| 12/27/2000 | CN1278249A Biphenyl derivatives as pharmaceuticals |
| 12/27/2000 | CN1278244A Dipeptide nitriles |
| 12/26/2000 | US6166239 Useful during oligonucleotide synthesis to protect nucleobase amines as well as tethered amines used for attaching functional moieties to oligonucleotides. |
| 12/26/2000 | US6166236 Vinyl carbonate and vinyl carbamate contact lens material monomers |
| 12/26/2000 | US6166223 Process for the preparation of 2,4-dimethylpyrrole |
| 12/26/2000 | US6166222 Reacting a pyrrolecarboxylic acid derivative in ammonia with an alkali metal or alkaline earth metal and then an aqueos salt solution of a alkyl- or silyl-leaving group compound |
| 12/26/2000 | US6166220 Ethylenically unsaturated imidazidolidinone monomers |
| 12/26/2000 | US6166063 Antidiabetic agents; antiarthritic agents; osteoporosis |
| 12/26/2000 | US6166036 Lp(a)-lowering agent and apolipoprotein (a) formation suppressing agent |
| 12/26/2000 | US6166035 1,4-dihydropyridine derivatives and their use in therapy |
| 12/26/2000 | US6166020 Aryl and heteroaryl alkoxynaphthalene derivatives |
| 12/26/2000 | US6166015 Pyrrolidine derivatives-CCR-3 receptor antagonists |
| 12/26/2000 | US6166009 For clinical treatment of painful, hyperalgesic and/or inflammatory conditions in which c-fibers play a pathophysiological role by eliciting neurogenic pain or inflammation |
| 12/26/2000 | US6165980 Distamycin derivatives, wherein the distamycin formyl group is substituted by a benzoyl group bearing alkylating group a bis-halo-ethylamino or a n-alkyl-n-haloethyl-amino group, while amidine group is substituted by various nitrogen groups |
| 12/26/2000 | US6165672 Reaction of potassium carbonate, tetramethylammonium hydroxide or sodium hydroxide with acetate of maleimidealkyl acetate to produce maleimide based monomers |
| 12/21/2000 | WO2000076991A1 Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines |
| 12/21/2000 | WO2000076974A2 Oligomers and polymers of cyclic imino carboxylic acids |
| 12/21/2000 | WO2000076971A2 Serine protease inhibitors |
| 12/21/2000 | WO2000076965A1 Removal of contaminants from n-methyl-2-pyrrolidone |
| 12/21/2000 | WO2000076489A2 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits |
| 12/21/2000 | WO2000053581A3 Heterocyclic compounds having antitumor activity |
| 12/21/2000 | WO2000053579A3 Solid phase synthesis of 4-aminoproline derivatives and/or combinatorial libraries thereof |
| 12/21/2000 | WO2000046193A3 Ether derivatives having neuronal activity |
| 12/21/2000 | WO2000044709A3 ACETYLENIC α-AMINO ACID-BASED SULFONAMIDE HYDROXAMIC ACID TACE INHIBITORS |
| 12/21/2000 | DE19927912A1 Catalytic preparation of cyclic and/or polymer compounds by educt metathesis is performed in the presence of one or more heterogeneous catalysts and ionic liquids |
| 12/21/2000 | DE19927612A1 New naphthyloxy, naphthylthio and naphthylamino substituted phenyl-uracil derivatives useful as herbicides, especially for selective weed control in crops |
| 12/21/2000 | CA2375920A1 Compounds |
| 12/21/2000 | CA2375551A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits |
| 12/21/2000 | CA2374627A1 Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines |
| 12/20/2000 | EP1061073A1 (R-(R*R*))-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl-3-phenyl-4((phenylamino)-carbonyl)-1H-pyrrole-1-heptanoic acid, its lactone form and salts thereof |
| 12/20/2000 | EP1061072A1 Pyrrolic compounds with a high herbicidal activity and their agronomic use |
| 12/20/2000 | EP1060178A1 Heterocyclic compounds as inhibitors of rotamase enzymes |
| 12/20/2000 | CN1059670C Ester compounds, its producing process and use. harmful bios controlling agent with it as effective ingredient and method for preventing and controlling the harmful bioses |
| 12/19/2000 | US6162928 Catalytic dehydrogenation of (substituted) pyrrolidine to pyrroles using as catalyst palladium on oxides of rare earth or group 4 metals, or platinum and palladium on oxides of aluminum, rare earth or group 4 metals, and 1a or 2a oxides |
| 12/19/2000 | US6162927 (2s,3r,4s)-2-(2,2-dimethylpentyl)-4-(7-methoxy-1,3-benzodioxol-5-yl)-1-(n,n-di(n-butyl)aminocarbonylmethyl)-pyrrolidine-3-carboxylic acid, or salt or ester thereof, in pure form; adminstering to treat hypertension, other diseases |
| 12/19/2000 | US6162812 Pharmaceutical compositions containing HIV protease inhibitors and methods of their use |
| 12/19/2000 | US6162445 Polyaromatic propynyl compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 12/19/2000 | US6162425 A keratin-reducing agent without allergic and sensitizing reactions |
| 12/14/2000 | WO2000047547A3 Cycloalkyl amine compounds and uses thereof |
| 12/13/2000 | EP1058698A1 Preparation for prevention and healing of inflammation affections |
| 12/13/2000 | EP1058682A1 Heterocyclic diarylmethylene derivatives, methods of preparing them and their uses in therapeutics |
| 12/13/2000 | CN1276785A N-aroylphenylalanine derivs. |
| 12/12/2000 | US6160176 Anticoagulant agents |
| 12/12/2000 | US6160134 Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines |
| 12/12/2000 | US6160128 Tritioacetylating reagents and processes for preparation thereof |
| 12/12/2000 | US6160126 Useful in preparing guanidine derivatives useful as insecticides and miticides |
| 12/12/2000 | US6159995 Substituted diaminocarboxylic acids |
| 12/12/2000 | US6159983 Method and composition for treatment of inflammatory bowel disease |
| 12/12/2000 | US6159973 Aromatic amides, their preparation process, the compositions containing them and their use as pesticides |
| 12/07/2000 | WO2000073299A1 Sulfonamide compounds with pharmaceutical activity |
| 12/07/2000 | WO2000073271A1 Mutual salt of amlodipine and atorvastatin |
| 12/07/2000 | WO2000073270A1 Remedies for periodontal diseases |
| 12/07/2000 | WO2000073258A1 Therapeutically and/or nutritionally enhanced derivatives of active ingredients and orally administrable compositions containing same |
| 12/07/2000 | WO2000072844A1 Neuronal death inhibitors |
| 12/07/2000 | WO2000048584A3 Aroyl aminoacyl pyrroles for use in the treatment of neuropathic pain |
| 12/07/2000 | WO2000009104A3 Use of sulfonamides for treating vision and memory disorders |
| 12/07/2000 | CA2374921A1 Neuronal death inhibitors |
| 12/06/2000 | EP1057485A1 Potassium channel activators |
| 12/06/2000 | EP1056733A1 Histamine h3 receptor ligands |
| 12/06/2000 | EP1056718A1 Anti-retroviral functionalised aromatic compounds |
| 12/06/2000 | EP1056717A1 Arylphenyl-substituted cyclic keto-enols |
| 12/06/2000 | EP1056704A1 Antitumor agents |
| 12/06/2000 | CN1275977A Heterocyclic thioesters and ketones |
| 12/05/2000 | US6156908 Cyclizing a 3-amino-2-oxoamino-5-methylsulfonium compound to for 3-amino-2-oxo-pyrrolidines as an end product |
| 12/05/2000 | US6156889 Reagent useful for cleaving a protected functional group |
| 12/05/2000 | US6156769 Antipruitus drugs for mammals |
| 12/05/2000 | US6156136 N,N'-azobis-nitroazoles and analogs thereof as igniter compounds for use in energetic compositions |
| 11/30/2000 | WO2000071572A1 Substituted beta-alanine derivatives as cell adhesion inhibitors |
| 11/30/2000 | WO2000071529A1 Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions |